(Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing

Detalhes bibliográficos
Autor(a) principal: Frota, Sónia
Data de Publicação: 2021
Outros Autores: Cruz, Marisa, Cardoso, Rita, Guimarães, Isabel, Ferreira, Joaquim J, Pinto, Serge, Vigario, Marina
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/49541
Resumo: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
id RCAP_d3f919d3000a3a7977937909561230dd
oai_identifier_str oai:repositorio.ul.pt:10451/49541
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasingProsodyParkinson’s diseaseIntonationProsodic phrasingProsodic phonologyIntonational phonologyAutosegmental–metrical (AM) approachSpeech productionLevodopaDisease duration© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).The phonology of prosody has received little attention in studies of motor speech disorders. The present study investigates the phonology of intonation (nuclear contours) and speech chunking (prosodic phrasing) in Parkinson’s disease (PD) as a function of medication intake and duration of the disease. Following methods of the prosodic and intonational phonology frameworks, we examined the ability of 30 PD patients to use intonation categories and prosodic phrasing structures in ways similar to 20 healthy controls to convey similar meanings. Speech data from PD patients were collected before and after a dopaminomimetic drug intake and were phonologically analyzed in relation to nuclear contours and intonational phrasing. Besides medication, disease duration and the presence of motor fluctuations were also factors included in the analyses. Overall, PD patients showed a decreased ability to use nuclear contours and prosodic phrasing. Medication improved intonation regardless of disease duration but did not help with dysprosodic phrasing. In turn, disease duration and motor fluctuations affected phrasing patterns but had no impact on intonation. Our study demonstrated that the phonology of prosody is impaired in PD, and prosodic categories and structures may be differently affected, with implications for the understanding of PD neurophysiology and therapy.This research was funded by Fundação para a Ciência e Tecnologia, Portugal (Grant FCT-ANR/NEU-SCC/0005/2013, PI J.J.F.; and Grant UIDB/00214/2020, Center of Linguistics of the University of Lisbon). The APC was funded by Grant UIDB/00214/2020.MDPIRepositório da Universidade de LisboaFrota, SóniaCruz, MarisaCardoso, RitaGuimarães, IsabelFerreira, Joaquim JPinto, SergeVigario, Marina2021-09-17T15:55:46Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/49541engBrain Sci. 2021 Aug 20;11(8):110010.3390/brainsci110811002076-3425info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:53:24Zoai:repositorio.ul.pt:10451/49541Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:01:10.197300Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing
title (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing
spellingShingle (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing
Frota, Sónia
Prosody
Parkinson’s disease
Intonation
Prosodic phrasing
Prosodic phonology
Intonational phonology
Autosegmental–metrical (AM) approach
Speech production
Levodopa
Disease duration
title_short (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing
title_full (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing
title_fullStr (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing
title_full_unstemmed (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing
title_sort (Dys)Prosody in Parkinson’s Disease: effects of medication and disease duration on intonation and prosodic phrasing
author Frota, Sónia
author_facet Frota, Sónia
Cruz, Marisa
Cardoso, Rita
Guimarães, Isabel
Ferreira, Joaquim J
Pinto, Serge
Vigario, Marina
author_role author
author2 Cruz, Marisa
Cardoso, Rita
Guimarães, Isabel
Ferreira, Joaquim J
Pinto, Serge
Vigario, Marina
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Frota, Sónia
Cruz, Marisa
Cardoso, Rita
Guimarães, Isabel
Ferreira, Joaquim J
Pinto, Serge
Vigario, Marina
dc.subject.por.fl_str_mv Prosody
Parkinson’s disease
Intonation
Prosodic phrasing
Prosodic phonology
Intonational phonology
Autosegmental–metrical (AM) approach
Speech production
Levodopa
Disease duration
topic Prosody
Parkinson’s disease
Intonation
Prosodic phrasing
Prosodic phonology
Intonational phonology
Autosegmental–metrical (AM) approach
Speech production
Levodopa
Disease duration
description © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
publishDate 2021
dc.date.none.fl_str_mv 2021-09-17T15:55:46Z
2021
2021-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/49541
url http://hdl.handle.net/10451/49541
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Brain Sci. 2021 Aug 20;11(8):1100
10.3390/brainsci11081100
2076-3425
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134559934087168

Registros relacionados